fbpx

Dentsply, GlaxoSmithKline sign co-branding agreement

York-based dental supply company Dentsply International Inc. has signed an agreement with GlaxoSmithKline for a co-branded line of products to combat tooth sensitivity, the companies said.

The partnership allows Dentsply to develop a line of sensitivity products under its Nupro brand and containing GlaxoSmithKline’s NovaMin technology. The products will be co-branded with GlaxoSmithKline’s Sensodyne brand, according to a news release.

United Kingdom-based GlaxoSmithKline is a research-based health care and pharmaceutical company.

Shares of Dentsply are traded on the Nasdaq under the ticker symbol XRAY.

Business Events

The Future of Higher Ed Summit

Tuesday, September 29, 2020
The Future of Higher Ed Summit

Forty Under 40

Wednesday, September 30, 2020
Forty Under 40

Game Changers

Monday, November 02, 2020
Game Changers

Real Estate & Development Summit

Tuesday, November 10, 2020
Real Estate & Development Summit